Dupixent and Captopril drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Dupixent (dupilumab) and Captopril (captopril). Common drug interactions include drug ineffective among females and nasal congestion among males.

The phase IV clinical study analyzes what interactions people have when they take Dupixent and Captopril. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.

What is Dupixent?

Dupixent has active ingredients of dupilumab. eHealthMe is studying from 257,631 Dupixent users. Check the latest studies of Dupixent.

What is Captopril?

Captopril has active ingredients of captopril. It is often used in high blood pressure. eHealthMe is studying from 17,438 Captopril users. Check the latest studies of Captopril.



On Jul, 19, 2026

12 people who take Dupixent and Captopril together, and have interactions are studied.

Dupixent and Captopril drug interactions.

What are the common drug interactions of Dupixent and Captopril, by gender? *:

female:

  1. Drug ineffective
  2. Dry skin
  3. Ear disorder
  4. Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters)
  5. Insomnia (sleeplessness)
  6. Pruritus (severe itching of the skin)
  7. Skin exfoliation (removal of the oldest dead skin cells)
  8. Skin fissures (a crack in the skin)
  9. Skin haemorrhage (bleeding into skin)
  10. Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it)

male:

  1. Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels)
  2. Pruritus (severe itching of the skin)
  3. Skin exfoliation (removal of the oldest dead skin cells)
  4. Skin fissures (a crack in the skin)
  5. Skin haemorrhage (bleeding into skin)
  6. Eye irritation
  7. Rash macular (small, flat red spots)
  8. Therapeutic response unexpected
  9. Blood glucose increased
  10. Cough

What are the common drug interactions of Dupixent and Captopril, by age (0-1 to 60+)? *:

0-1:

  1. Dry skin
  2. Ear disorder
  3. Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters)
  4. Insomnia (sleeplessness)
  5. Pruritus (severe itching of the skin)
  6. Skin exfoliation (removal of the oldest dead skin cells)
  7. Skin fissures (a crack in the skin)
  8. Skin haemorrhage (bleeding into skin)

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Erythema (redness of the skin)
  2. Hypersensitivity
  3. Memory impairment
  4. Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels)
  5. Pain
  6. Rash
  7. Swelling
  8. Eye irritation
  9. Rash macular (small, flat red spots)
  10. Therapeutic response unexpected

60+:

  1. Blood glucose increased
  2. Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels)
  3. Pruritus (severe itching of the skin)
  4. Skin exfoliation (removal of the oldest dead skin cells)
  5. Skin fissures (a crack in the skin)

What are the existing conditions these people have? *

  1. Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 6 people, 50.00%
  2. Asthma: 3 people, 25.00%
  3. Nasal Congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels): 1 person, 8.33%
  4. Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Dupixent and Captopril?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Dupixent and Captopril:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Dupixent:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Captopril:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Dupixent and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Captopril and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on dupilumab and captopril (the active ingredients of Dupixent and Captopril, respectively), and Dupixent and Captopril (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: